Activaero and Chiesi to develop new treatment solution for cystic fibrosis patients

Germany-based Activaero has entered into research collaboration with Italian pharmaceutical firm Chiesi Farmaceutici for the development of an effective solution to treat patients with cystic fibrosis (CF).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news